BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31451264)

  • 1. The impact of pretransplant malnutrition on allogeneic hematopoietic stem cell transplantation outcomes.
    Hirose EY; de Molla VC; Gonçalves MV; Pereira AD; Szor RS; da Fonseca ARBM; Fatobene G; Serpa MG; Xavier EM; Tucunduva L; Rocha V; Novis Y; Arrais-Rodrigues C
    Clin Nutr ESPEN; 2019 Oct; 33():213-219. PubMed ID: 31451264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malnutrition Prevention after Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Prospective Explorative Interventional Study with an Oral Polymeric Formulation Enriched with Transforming Growth Factor Beta 2 (TGF-β2).
    Morello E; Arena F; Malagola M; Farina M; Polverelli N; Cavagna E; Colnaghi F; Donna L; Zollner T; Accorsi Buttini E; Andreoli M; Ricci C; Leoni A; Samarani E; Bertulli A; Leali D; Bernardi S; Russo D
    Nutrients; 2022 Aug; 14(17):. PubMed ID: 36079847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutritional intervention with TGF-beta enriched food for special medical purposes (TGF-FSMP) is associated with a reduction of malnutrition, acute GVHD, pneumonia and may improve overall survival in patients undergoing allogeneic hematopoietic stem transplantation.
    Morello E; Brambilla G; Bernardi S; Villanacci V; Carlessi M; Farina M; Radici V; Samarani E; Pellizzeri S; Polverelli N; Leoni A; Andreoli M; Arena F; Ricci C; Malagola M; Russo D
    Transpl Immunol; 2023 Dec; 81():101954. PubMed ID: 37931667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutritional status of allogeneic hematopoietic stem cell transplantation recipients: influencing risk factors and impact on survival.
    El-Ghammaz AMS; Ben Matoug R; Elzimaity M; Mostafa N
    Support Care Cancer; 2017 Oct; 25(10):3085-3093. PubMed ID: 28439725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-Generated Subjective Global Assessment as a prognosis tool in patients with multiple myeloma.
    Kim HS; Lee JY; Lim SH; Cho J; Kim SJ; Jang JH; Kim WS; Jung CW; Kim K
    Nutrition; 2017 Apr; 36():67-71. PubMed ID: 28336110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a Nutritional Risk Index on Clinical Outcomes after Allogeneic Hematopoietic Cell Transplantation.
    Sagou K; Ozeki K; Ukai S; Adachi Y; Fukushima N; Kohno A
    Biol Blood Marrow Transplant; 2019 Nov; 25(11):2287-2296. PubMed ID: 31284071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graft-versus-tumor effect according to type of graft-versus-host disease defined by National Institutes of Health consensus criteria and associated outcomes.
    Cho BS; Lee SE; Song HH; Lee JH; Yahng SA; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW
    Biol Blood Marrow Transplant; 2012 Jul; 18(7):1136-43. PubMed ID: 22261380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutritional risk factors predict severe acute graft-versus-host disease and early mortality in pediatric allogeneic hematopoietic stem cell transplantation.
    Kerby EH; Li Y; Getz KD; Smith EC; Smith LT; Bunin NJ; Seif AE
    Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 29080380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two pretransplant predictive models and a flexible HCT-CI using different cut off points to determine low-, intermediate-, and high-risk groups: the flexible HCT-CI Is the best predictor of NRM and OS in a population of patients undergoing allo-RIC.
    Barba P; Piñana JL; Martino R; Valcárcel D; Amorós A; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
    Biol Blood Marrow Transplant; 2010 Mar; 16(3):413-20. PubMed ID: 19922807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malnutrition and clinical outcomes post alloSCT.
    Jefferis M; Andersen S; Brown T; Curley C; Bauer J
    J Hum Nutr Diet; 2023 Aug; 36(4):1253-1260. PubMed ID: 36511299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decline in nutritional status is associated with prolonged length of stay in hospitalized patients admitted for 7 days or more: A prospective cohort study.
    Allard JP; Keller H; Jeejeebhoy KN; Laporte M; Duerksen DR; Gramlich L; Payette H; Bernier P; Davidson B; Teterina A; Lou W
    Clin Nutr; 2016 Feb; 35(1):144-152. PubMed ID: 25660316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic microangiopathy with concomitant GI aGVHD after allogeneic hematopoietic stem cell transplantation: Risk factors and outcome.
    Zhang XH; Liu X; Wang QM; He Y; Zhu XL; Zhang JM; Han W; Chen H; Chen YH; Wang FR; Wang JZ; Zhang YY; Mo XD; Chen Y; Wang Y; Fu HX; Chang YJ; Xu LP; Liu KY; Huang XJ
    Eur J Haematol; 2018 Feb; 100(2):171-181. PubMed ID: 29114931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
    Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
    Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
    El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM; Wood WA; Ahmed I; Aljurf M; Szer J; Beattie SM; Battiwalla M; Dandoy C; Diaz MA; D'Souza A; Freytes CO; Gajewski J; Gergis U; Hashmi SK; Jakubowski A; Kamble RT; Kindwall-Keller T; Lazarus HM; Malone AK; Marks DI; Meehan K; Savani BN; Olsson RF; Rizzieri D; Steinberg A; Speckhart D; Szwajcer D; Schoemans H; Seo S; Ustun C; Atsuta Y; Dalal J; Sales-Bonfim C; Khera N; Hahn T; Saber W
    Cancer; 2017 May; 123(10):1828-1838. PubMed ID: 28102896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malnutrition (subjective global assessment) scores and serum albumin levels, but not body mass index values, at initiation of dialysis are independent predictors of mortality: a 10-year clinical cohort study.
    Chan M; Kelly J; Batterham M; Tapsell L
    J Ren Nutr; 2012 Nov; 22(6):547-57. PubMed ID: 22406122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malnutrition associated with nutrition impact symptoms and localization of the disease: Results of a multicentric research on oncological nutrition.
    de Pinho NB; Martucci RB; Rodrigues VD; D'Almeida CA; Thuler LCS; Saunders C; Jager-Wittenaar H; Peres WAF
    Clin Nutr; 2019 Jun; 38(3):1274-1279. PubMed ID: 29853223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of antithymocyte globulin on outcomes of allogeneic hematopoietic cell transplantation with TBI.
    Nagler A; Labopin M; Dholaria B; Niittyvuopio R; Maertens J; Poiré X; Cornelissen J; Reményi P; Bourhis JH; Beguin Y; Malladi R; Kerre T; Schroyens W; Savani BN; Mohty M
    Blood Adv; 2019 Jul; 3(13):1950-1960. PubMed ID: 31262738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality, length of stay and costs associated with acute graft-versus-host disease during hospitalization for allogeneic hematopoietic stem cell transplantation.
    Yu J; Parasuraman S; Shah A; Weisdorf D
    Curr Med Res Opin; 2019 Jun; 35(6):983-988. PubMed ID: 30461314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.